02 May 2003
Camptothecin induced topoisomerase I-DNA complexes are targeted and reversed by poly(ADP-ribose)
M. Malanga, O. Cohausz, F. AlthausMed Sci Monit 2003; 9(1): 38-0 :: ID: 15101
Abstract
Camptothecin (CPT) and its clinically used congeners base their potency as anticancer drugs on the ability to stabilize topoisomerase I-cleaved DNA covalent complexes; such long-lived nucleoprotein complexes constitute a challenge to genomic integrity and cell viability as they can be converted in potentially lethal DNA damage upon collision with replication/transcription machineries [1]. Many DNA structural lesions have been shown to have a similar ‘poisoning’ effect [2]. The observation that PARP inhibitors potentiate the cytotoxicity of CPT in irradiated cells [3] suggests a correlation between poly(ADP-ribose) synthesis and cell’s ability to cope with topoisomerase I-induced DNA damage. Using an in vitro system we investigated whether the steady state level of topoisomerase I-DNA complexes could be modulated by poly(ADP-ribosyl)ation. We observed that both PARP-1 and PARP-2 in their automodified form reduced topoisomerase I-DNA covalent complexes, while they had little or no effect in their native state. The decrease in the number of nucleoprotein complexes occurred even in the presence of CPT and appeared to be specifically dependent on, and proportional to, the amount of PARP-bound poly(ADP-ribose). We found that poly(ADP-ribose) interacts noncovalently with topoisomerase I and identified two binding motifs at critical sites for the enzyme activity. Further experiments revealed that topoisomerase I in covalent complex with its substrate was a preferred target for poly(ADP-ribose). Such specific targeting resulted in a complete reversion of the cleavage complexes, in spite of the stabilizing effect of CPT. Work is in progress to evaluate the occurrence of such poly(ADP-ribose)-mediated repair of topoisomerase I-DNA covalent complexes in living cells. References: 1.Kohn KW, Pommier Y: Annals NY Acad Sci, 2000; 922: 11-26 2.Pourquier P, Waltman JL, Urasaki Y et al: Cancer Res, 2001; 61: 53-58 3.Bowman KJ, Newell DR, Calvert AH, Curtin NJ: Br J Cancer, 2001; 84: 106-112
Keywords: PARP-2, noncovalent interactions, DNA Repair
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






